BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21790212)

  • 41. The Significant Role of microRNAs in Gliomas Angiogenesis: A Particular Focus on Molecular Mechanisms and Opportunities for Clinical Application.
    Mafi A; Mannani R; Khalilollah S; Hedayati N; Salami R; Rezaee M; Dehmordi RM; Ghorbanhosseini SS; Alimohammadi M; Akhavan-Sigari R
    Cell Mol Neurobiol; 2023 Oct; 43(7):3277-3299. PubMed ID: 37414973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular diagnostics as a tool to personalize treatment in adult glioma patients.
    Jeuken JW; van der Maazen RW; Wesseling P
    Technol Cancer Res Treat; 2006 Jun; 5(3):215-29. PubMed ID: 16700618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis.
    Gao H; Yu B; Yan Y; Shen J; Zhao S; Zhu J; Qin W; Gao Y
    J Neurosurg; 2013 Apr; 118(4):846-53. PubMed ID: 23082878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glioma proteomics: status and perspectives.
    Niclou SP; Fack F; Rajcevic U
    J Proteomics; 2010 Sep; 73(10):1823-38. PubMed ID: 20332038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased Expression of miR-15b in Human Gliomas is Associated with Poor Prognosis.
    Sun G; Yan S; Shi L; Wan Z; Jiang N; Li M; Guo J
    Cancer Biother Radiopharm; 2015 May; 30(4):169-73. PubMed ID: 25811315
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-584 functions as a tumor suppressor and targets PTTG1IP in glioma.
    Wang XP; Deng XL; Li LY
    Int J Clin Exp Pathol; 2014; 7(12):8573-82. PubMed ID: 25674221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microarray analysis of the aberrant microRNA expression pattern in gliomas of different grades.
    Zhu XP; Mou KJ; Xu QF; Tang JH; Huang GH; Xu JP; Li GH; Ai SJ; Hugnot JP; Zhou Z; Lv SQ
    Oncol Rep; 2015 Jul; 34(1):318-24. PubMed ID: 25954994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The molecular biology of WHO grade II gliomas.
    Marko NF; Weil RJ
    Neurosurg Focus; 2013 Feb; 34(2):E1. PubMed ID: 23373446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-200a impairs glioma cell growth, migration, and invasion by targeting SIM2-s.
    Su Y; He Q; Deng L; Wang J; Liu Q; Wang D; Huang Q; Li G
    Neuroreport; 2014 Jan; 25(1):12-7. PubMed ID: 24162743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Notch inhibition via micro-RNA blocks glioma development.
    Berry N; Gursel DB; Boockvar JA
    Neurosurgery; 2012 Apr; 70(4):N20-2. PubMed ID: 22426058
    [No Abstract]   [Full Text] [Related]  

  • 53. miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway.
    Jiang L; Wang C; Lei F; Zhang L; Zhang X; Liu A; Wu G; Zhu J; Song L
    Oncotarget; 2015 Apr; 6(10):8286-99. PubMed ID: 25823655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC.
    Sasayama T; Nishihara M; Kondoh T; Hosoda K; Kohmura E
    Int J Cancer; 2009 Sep; 125(6):1407-13. PubMed ID: 19536818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrated dia-gnostics of diffuse gliomas.
    Hendrych M; Valeková H; Kazda T; Lakomý R; Šána J; Jančálek R; Slabý O; Hermanová M
    Klin Onkol; 2020; 33(4):248-259. PubMed ID: 32894953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional roles of enhancer of zeste homolog 2 in gliomas.
    Yin Y; Qiu S; Peng Y
    Gene; 2016 Jan; 576(1 Pt 2):189-94. PubMed ID: 26435191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liquid biopsies in patients with diffuse glioma.
    Best MG; Sol N; Zijl S; Reijneveld JC; Wesseling P; Wurdinger T
    Acta Neuropathol; 2015 Jun; 129(6):849-65. PubMed ID: 25720744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
    Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
    Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of IL-8 gene expression in gliomas by microRNA miR-93.
    Fabbri E; Brognara E; Montagner G; Ghimenton C; Eccher A; Cantù C; Khalil S; Bezzerri V; Provezza L; Bianchi N; Finotti A; Borgatti M; Moretto G; Chilosi M; Cabrini G; Gambari R
    BMC Cancer; 2015 Oct; 15():661. PubMed ID: 26449498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients.
    Wang Q; Wang L; Li D; Deng J; Zhao Z; He S; Zhang Y; Tu Y
    Cancer Epidemiol; 2013 Feb; 37(1):79-84. PubMed ID: 22999822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.